Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Treated Patients 13 to 30

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Mar 11, 2022 3:21pm

261 Views

Post# 34507675

RE:RE:RE:RE:RE:RE:RE:RE:Treated Patients 13 to 30

Having pending results at least allow us to know these patients have been treated. That's wise. So this is still precious data. Some have a weird reasoning of not wanting such valuable data.

Imagine if we wouldn't have been informed of the last 7 patients with a "pending" result. The same posters would probably have been worried about the slow pace of enrollment because these 7 patients would not have appeared on the list! So we would have been awared of only 26 patients, instead of 33!

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario